Dermatological Drugs Global Market Report 2025

Description

Dermatological drugs are medications formulated to treat conditions affecting the skin, hair, and nails by reducing inflammation, controlling infections, and managing symptoms such as itching and redness. These drugs are essential in dermatology, helping to address both common and severe skin disorders while enhancing patient comfort and quality of life.

The primary drug classes in dermatological treatments include corticosteroids, retinoids, antibiotics, antifungals, calcineurin inhibitors, and others. Corticosteroids are a class of steroid hormones that reduce inflammation and suppress immune system activity by mimicking cortisol, a natural hormone produced by the adrenal glands. These drugs can be administered through various routes, including topical, oral, and parenteral administration. They are used to treat multiple conditions such as acne, psoriasis, rosacea, alopecia, and more. Distribution channels include hospital pharmacies, retail pharmacies, and other outlets.

The dermatological drugs market research report is one of a series of new reports from The Business Research Company that provides dermatological drugs market statistics, including dermatological drugs industry global market size, regional shares, competitors with a dermatological drugs market share, detailed dermatological drugs market segments, market trends and opportunities, and any further data you may need to thrive in the dermatological drugs industry. This dermatological drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dermatological drugs market size has grown strongly in recent years. It will grow from $20.06 billion in 2024 to $22.04 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth during the historic period was driven by the rising prevalence of skin disorders, advancements in drug formulation and delivery, increasing awareness of skincare and aesthetics, the expansion of the aging population, and the growing demand for over-the-counter dermatological products.

The dermatological drugs market size is expected to see strong growth in the next few years. It will grow to $31.75 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The projected growth in the forecast period can be attributed to advancements in biologics and targeted therapies, the increasing adoption of teledermatology and digital health, a rising prevalence of lifestyle-related skin conditions, growing demand for personalized and regenerative medicine, and expanding research in microbiome-based dermatological treatments. Key trends expected in this period include nanotechnology-based drug delivery, AI-driven dermatological diagnostics, microbiome-targeted therapies, 3D bioprinting for skin regeneration, gene editing, and RNA-based treatments.

The increasing demand for cosmetic dermatology procedures is expected to drive the expansion of the dermatological drugs market. Cosmetic dermatology is a specialized field that enhances a person's appearance through various non-surgical treatments and procedures. This growing demand is fueled by heightened consumer awareness of aesthetic treatments, advancements in skincare technology, and a preference for non-invasive procedures to improve appearance and counteract aging. The rising popularity of cosmetic dermatology treatments, such as anti-aging and skin rejuvenation procedures, is leading to the development of advanced dermatological drugs that provide safe, effective, and minimally invasive solutions. For example, in January 2023, the International Society of Aesthetic Plastic Surgery reported that over 12.8 million surgical and 17.5 million non-surgical procedures were performed globally, reflecting a 19.3% increase from the previous period. Additionally, in 2022, plastic surgeons worldwide conducted more than 14.9 million surgical and 18.8 million non-surgical procedures, marking an 11.2% rise in total treatments. As a result, the growing number of cosmetic dermatology procedures is fueling the expansion of the dermatological drugs market.

Leading companies in the dermatological drugs market are focusing on developing biologic treatments to address chronic skin conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. Biologic therapies target specific immune pathways, offering more effective and long-lasting relief compared to traditional treatments. In September 2024, Eli Lilly and Company, a US-based pharmaceutical firm, received approval for Ebglyss (lebrikizumab), an interleukin-13 (IL-13) inhibitor designed to treat moderate-to-severe atopic dermatitis in patients aged 12 and older. This approval represents a significant advancement, providing a new biologic treatment option for individuals who have not achieved sufficient symptom control with topical therapies. Ebglyss aims to enhance patients' quality of life by reducing severe itching and skin inflammation associated with moderate-to-severe atopic dermatitis.

In September 2024, Organon, a US-based pharmaceutical company, acquired Dermavant Sciences Ltd. for $1.2 billion. This acquisition brings Dermavant's flagship product, VTAMA (tapinarof) cream, 1%, into Organon's portfolio. VTAMA is a non-steroidal topical treatment approved by the US Food and Drug Administration (FDA) for mild, moderate, and severe plaque psoriasis in adults. Dermavant Sciences Ltd. is a US-based immunodermatology company specializing in the development and commercialization of innovative dermatological treatments.

Major players in the dermatological drugs market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Bausch Health Companies Inc., Organon International, Galderma, Incyte Corporation, Glenmark Pharmaceuticals Ltd., Mayne Pharma Group Limited, Dermavant Sciences Inc., Taro Pharmaceutical Industries Ltd., Biofrontera AG, Almirall SA, UCB SA, LEO Pharma A/S, and Dermira Inc.

North America was the largest region in the dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dermatological drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dermatological drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dermatological drugs market consists of sales of creams, ointments, gels, and lotions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dermatological Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dermatological drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dermatological drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatological drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Corticosteroids; Retinoids; Antibiotics; Antifungals; Calcineurin Inhibitors; Other Drug Classes
2) By Administration: Topical Administration; Oral Administration; Parenteral Administration
3) By Indication: Acne; Psoriasis; Rosacea; Alopecia; Other Indications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
2) By Retinoids: Topical Retinoids; Oral Retinoids
3) By Antibiotics: Topical Antibiotics; Oral Antibiotics
4) By Antifungals: Topical Antifungals; Oral Antifungals
5) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors; Systemic Calcineurin Inhibitors
6) By Other Drug Classes: Biologics; JAK Inhibitors; Antihistamines; Photodynamic Therapy Agents
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Bayer AG; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34032

1. Executive Summary

2. Dermatological Drugs Market Characteristics

3. Dermatological Drugs Market Trends And Strategies

4. Dermatological Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dermatological Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Dermatological Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dermatological Drugs Market Growth Rate Analysis
5.4. Global Dermatological Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Dermatological Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Dermatological Drugs Total Addressable Market (TAM)

6. Dermatological Drugs Market Segmentation

6.1. Global Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Retinoids
Antibiotics
Antifungals
Calcineurin Inhibitors
Other Drug Classes
6.2. Global Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Administration
Oral Administration
Parenteral Administration
6.3. Global Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acne
Psoriasis
Rosacea
Alopecia
Other Indications
6.4. Global Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
6.5. Global Dermatological Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Corticosteroids
Oral Corticosteroids
Injectable Corticosteroids
6.6. Global Dermatological Drugs Market, Sub-Segmentation Of Retinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Retinoids
Oral Retinoids
6.7. Global Dermatological Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Antibiotics
Oral Antibiotics
6.8. Global Dermatological Drugs Market, Sub-Segmentation Of Antifungals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Antifungals
Oral Antifungals
6.9. Global Dermatological Drugs Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Calcineurin Inhibitors
Systemic Calcineurin Inhibitors
6.10. Global Dermatological Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
JAK Inhibitors
Antihistamines
Photodynamic Therapy Agents

7. Dermatological Drugs Market Regional And Country Analysis

7.1. Global Dermatological Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Dermatological Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dermatological Drugs Market

8.1. Asia-Pacific Dermatological Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dermatological Drugs Market

9.1. China Dermatological Drugs Market Overview
9.2. China Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dermatological Drugs Market

10.1. India Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dermatological Drugs Market

11.1. Japan Dermatological Drugs Market Overview
11.2. Japan Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dermatological Drugs Market

12.1. Australia Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dermatological Drugs Market

13.1. Indonesia Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dermatological Drugs Market

14.1. South Korea Dermatological Drugs Market Overview
14.2. South Korea Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dermatological Drugs Market

15.1. Western Europe Dermatological Drugs Market Overview
15.2. Western Europe Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dermatological Drugs Market

16.1. UK Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dermatological Drugs Market

17.1. Germany Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dermatological Drugs Market

18.1. France Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dermatological Drugs Market

19.1. Italy Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dermatological Drugs Market

20.1. Spain Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dermatological Drugs Market

21.1. Eastern Europe Dermatological Drugs Market Overview
21.2. Eastern Europe Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dermatological Drugs Market

22.1. Russia Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dermatological Drugs Market

23.1. North America Dermatological Drugs Market Overview
23.2. North America Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dermatological Drugs Market

24.1. USA Dermatological Drugs Market Overview
24.2. USA Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dermatological Drugs Market

25.1. Canada Dermatological Drugs Market Overview
25.2. Canada Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dermatological Drugs Market

26.1. South America Dermatological Drugs Market Overview
26.2. South America Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dermatological Drugs Market

27.1. Brazil Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dermatological Drugs Market

28.1. Middle East Dermatological Drugs Market Overview
28.2. Middle East Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dermatological Drugs Market

29.1. Africa Dermatological Drugs Market Overview
29.2. Africa Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dermatological Drugs Market Competitive Landscape And Company Profiles

30.1. Dermatological Drugs Market Competitive Landscape
30.2. Dermatological Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Dermatological Drugs Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. GlaxoSmithKline Plc
31.3. Eli Lilly and Company
31.4. Amgen Inc.
31.5. Bausch Health Companies Inc.
31.6. Organon International
31.7. Galderma
31.8. Incyte Corporation
31.9. Glenmark Pharmaceuticals Ltd.
31.10. Mayne Pharma Group Limited
31.11. Dermavant Sciences Inc.
31.12. Taro Pharmaceutical Industries Ltd.
31.13. Biofrontera AG
31.14. Almirall SA
31.15. UCB SA

32. Global Dermatological Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dermatological Drugs Market

34. Recent Developments In The Dermatological Drugs Market

35. Dermatological Drugs Market High Potential Countries, Segments and Strategies

35.1 Dermatological Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Dermatological Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Dermatological Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer